MedPath

Nevramin Tablets

Registration Number: MAL06111330XCZ

Approved
Approval ID

37f8fa053943d1bd

Registration Number

MAL06111330XCZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

300Tablet TabletsAvailable
Package Size: 300Tablet Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (3)

CyanocobalaminActive
Monograph: 维生素B12
Pyridoxine HCIActive
Monograph: pyridoxine hci
Fursultiamine HydrochlorideActive
Monograph: fursultiamine hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nevramin Tablets - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform